RIT with Y90-Ibritumomab Tiuxetan in Follicular Non-Hodgkin Lymphoma: Evaluation of Recent Outcomes in a Single Institution

Background. Based on historical data we reviewed our hospital clinical database to analyse our updated information and therapy outcomes of follicular non-Hodgkin lymphoma (F-NHL) patients treated with (90)Y-Ibritumomab tiuxetan. Patients and Methods. Between 2005 and 2011, 56 F-NHL patients were inc...

Descripción completa

Detalles Bibliográficos
Autores principales: Andrade Campos, Marcio Miguel, Montes Limón, Anel E., Grasa, Jose María, Lievano, Paola, Baringo, Teresa, Giraldo, Pilar
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2012
Materias:
Clinical Study
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3463194/
https://www.ncbi.nlm.nih.gov/pubmed/23049552
http://dx.doi.org/10.1155/2012/412742

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3463194/
https://www.ncbi.nlm.nih.gov/pubmed/23049552
http://dx.doi.org/10.1155/2012/412742

Ejemplares similares